ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders.
ProMetic uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics and orphan drugs.
ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, cancer and autoimmune diseases/inflammation.
2014 THIRD QUARTER FINANCIAL RESULTS WEBCAST
2014 THIRD QUARTER FINANCIAL RESULTS PRESENTATION
ProMetic BioProduction Corporate Video